Amgen Inc( AMGN) is the Stock of the Day at Real Money here on Monday as it has agreed to acquire the global rights to Celgene Corp.'s ( CELG) psoriasis medication Otezla for $13.4 billion in cashCelgene is selling Otezla so that regulators will allow its planned sale to Bristol-Myers Squibb Co( BMY) to proceedA lot of my neighbors in New Jersey ...
You have reached your free article limit. Try Real Money Free for 14 Days to continue reading this story and get access to money-making ideas.
Stay ahead of the market with Real Money where you'll get actionable investing ideas from over 30+ investing pros, money managers, journalists and analysts. Real Money allows you to interact directly with experts that give you a flood of opinions, analysis and trading advice found nowhere else.